Evidence map›Paper›PMID 28168836›Full record

ArticleMicrobial biotechnology2017

A rapid method for selecting suitable animal species for studying pathogen interactions with plasma protein ligands in vivo.

Clément Naudin, Ariane Schumski, Outi M H Salo-Ahen, Heiko Herwald, Emanuel Smeds

Open access · goldAbstract read
In one paragraph

Article in Microbial biotechnology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 99% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 0 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Clément NaudinDepartment of Clinical Sciences Lund, Division of Infection Medicine, Lund University, Lund, Sweden.
Ariane SchumskiDepartment of Clinical Sciences Lund, Division of Infection Medicine, Lund University, Lund, Sweden.
Outi M H Salo-AhenFaculty of Natural Sciences and Engineering, Pharmacy, Åbo Akademi University, Turku, Finland.
Heiko HerwaldDepartment of Clinical Sciences Lund, Division of Infection Medicine, Lund University, Lund, Sweden.
Emanuel SmedsDepartment of Clinical Sciences Lund, Division of Infection Medicine, Lund University, Lund, Sweden.ORCID 0000-0002-9689-826X
Lund University · SEÅbo Akademi University · FI

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Species tropism constitutes a serious problem for developing relevant animal models of infection. Human pathogens can express virulence factors that show specific selectivity to human proteins, while their affinity for orthologs from other species can vary significantly. Suitable animal species must be used to analyse whether virulence factors are potential targets for drug development. We developed an assay that rapidly predicts applicable animal species for studying virulence factors binding plasma proteins. We used two well-characterized Staphylococcus aureus proteins, SSL7 and Efb, to develop an ELISA-based inhibition assay using plasma from different animal species. The interaction between SSL7 and human C5 and the binding of Efb to human fibrinogen and human C3 was studied. Affinity experiments and Western blot analyses were used to validate the assay. Human, monkey and cat plasma interfered with binding of SSL7 to human C5. Binding of Efb to human fibrinogen was blocked in human, monkey, gerbil and pig plasma, while human, monkey, gerbil, rabbit, cat and guinea pig plasma inhibited the binding of Efb to human C3. These results emphasize the importance of choosing correct animal models, and thus, our approach is a rapid and cost-effective method that can be used to prevent unnecessary animal experiments.

Indexed as

Disease Models, AnimalHost-Pathogen InteractionsAnimalsBacterial ProteinsBlood ProteinsLigandsProtein BindingStaphylococcus aureusBacterial ProteinsBlood ProteinsLigands

Identifiers

PMID28168836
PMCPMC5404189
OpenAlexW2587574182

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.